Episode 173: Exploring the Emerging Role of GLP-1 Therapies in Neurology

Episode 173 of the NeurologyLive^® Mind Moments^® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis (MS), Parkinson disease, dementia, sleep disorders, and more.

In this Mind Moments episode, Pezhman Roohani, MD, neurologist and medical director of the teleneurology and telestroke program at Allina Health, joins the podcast to discuss the emerging role of GLP-1 receptor agonists across neurology. Roohani outlines where these therapies may have the greatest impact, highlighting stroke prevention, neurodegenerative diseases, idiopathic intracranial hypertension, and other areas being explored as researchers look beyond their established metabolic effects.

The conversation also examines what recent Alzheimer disease trial results mean for the future of GLP-1 research, including the potential importance of prevention and identifying patient subgroups most likely to benefit. Roohani discusses key cautions surrounding long-term use, muscle loss, nutrition, and lifestyle modification, as well as practical considerations when counseling patients. He closes by highlighting unanswered research questions and potential applications in neuroinflammation, traumatic brain injury, and addiction.

The stories featured in this week’s Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

• First-Ever Platform Trial for Progressive Supranuclear Palsy Enrolls Its Inaugural Participant
• FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
• Efgartigimod Meets Primary Endpoint in Phase 3 ALKIVIA Trial of Autoimmune Myositis

EPISODE BREAKDOWN

• 1:15 – Neurologic conditions showing the greatest promise for GLP-1 therapies
• 4:15 – GLP-1s in neurodegeneration following recent Alzheimer trial results
• 7:35 – Key cautions and limitations surrounding long-term GLP-1 use
• 9:35 – Neurology News Minute 
• 11:50– Counseling patients on lifestyle changes when initiating GLP-1 therapy
• 14:20 – Research priorities and emerging neurologic applications for GLP-1s

Click here to subscribe to the Mind Moments podcast. Be sure to leave a rating and review for the show. Thanks for listening!

Hoping to listen on your favorite podcast app? See below:

• Click here for Apple Podcasts
• Click here for Spotify
• Click here for Google Podcasts